Literature DB >> 16904244

A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS.

Rita Peila1, Berran Yucesoy, Lon R White, Victor Johnson, Michael L Kashon, Kim Wu, Helen Petrovitch, Michael Luster, Lenore J Launer.   

Abstract

The transforming growth factor-beta1 (TGF-beta1) is involved in post-ischemic neuronal rescue and in beta-amyloid turn-over. We hypothesized that the risk for dementia and related neuropathologies is modified by the TGF-beta1 functional genetic variants. The association of the TGF-beta1+29T-->C polymorphism with dementia was examined in a sample of 261 cases and 491 controls from the Honolulu-Asia Aging Study, including 282 subjects with autopsy data. Dementia was assessed in 1991 and 1994 by a multi-step protocol and standardized diagnostic criteria. The analysis was adjusted for demographic and vascular factors. Compared to the TT genotype, the TC and the CC genotypes were associated with a reduced risk for vascular dementia (OR(TC)=0.28, 95% confidence interval (CI): 0.1-0.9; OR(CC)=0.28, CI: 0.1-0.9), microinfarcts (OR(CC)=0.31, CI: 0.13-0.71) and cerebral amyloid angiopathy (OR(CC)=0.48, CI: 0.2-0.9). The CC genotype was associated with an increase risk of neocortical plaques (OR(CC)=4.34, CI: 1.6-11.8). These preliminary data suggest that the TGF genetic variability may be important in the risk of vascular related dementia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904244     DOI: 10.1016/j.neurobiolaging.2006.06.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

2.  Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease.

Authors:  Xin-Kang Tong; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2015-01-07       Impact factor: 6.200

Review 3.  Emerging molecular mechanisms of vascular dementia.

Authors:  Milagros C Romay; Camilo Toro; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

4.  Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer's disease.

Authors:  Wei-wei Chang; Liu Zhang; Yue-long Jin; Ying-shui Yao
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

5.  TGF-β induces TIAF1 self-aggregation via type II receptor-independent signaling that leads to generation of amyloid β plaques in Alzheimer's disease.

Authors:  M-H Lee; S-R Lin; J-Y Chang; L Schultz; J Heath; L-J Hsu; Y-M Kuo; Q Hong; M-F Chiang; C-X Gong; C-I Sze; N-S Chang
Journal:  Cell Death Dis       Date:  2010-12-23       Impact factor: 8.469

Review 6.  Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.

Authors:  Fan Su; Feng Bai; Zhijun Zhang
Journal:  Neurosci Bull       Date:  2016-08-27       Impact factor: 5.203

7.  Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease.

Authors:  Masahito Yamada
Journal:  Front Neurol       Date:  2012-04-25       Impact factor: 4.003

8.  Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.

Authors:  Lingmei Peng; Peng Li; Jian Chen; Ke Yan; Fuyuan Huo; Lina Han; Can Li; Sheng Tan; Xiaodan Jiang
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 9.  Cerebral amyloid angiopathy: emerging concepts.

Authors:  Masahito Yamada
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

10.  Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment.

Authors:  Paolo Bosco; Raffaele Ferri; Maria Grazia Salluzzo; Sabrina Castellano; Maria Signorelli; Ferdinando Nicoletti; Santo Di Nuovo; Filippo Drago; Filippo Caraci
Journal:  Curr Genomics       Date:  2013-04       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.